Benign Liver Masses
Hepatic Cysts
- Asymptomatic cysts are benign and require no follow-up
- Large cysts rarely present with abdominal pain and can be treated with surgical defenestration or, if surgery is contraindicated, with cyst aspiration and sclerotherapy
- Cystadenomas are distinguished from simple cysts by the presence of thick, complex walls on ultrasonography; they require surgical resection because of risk for malignancy.
Hepatic Adenoma
- Benign masses although larger ones may rupture and hemorrhage, or undergo malignant transformation.
- Associated with oral contraceptives and are eight times more common in women than men
- Other risk factors include androgen treatment, type 1 and 3 glycogen storage disease, and obesity
- Hepatic adenomas can be differentiated from focal nodular hyperplasia with MRI with bile-excreted contrast material, such as gadobenate dimeglumine or gadoxetate disodium, because they typically do not have normal biliary excretion
- Management:
- All patients taking oral contraceptives should discontinue those drugs and undergo follow-up CT or MRI every 6 to 12 months to confirm stability or regression in lesion size. The duration of surveillance and treatment depends on subsequent imaging findings
- In women not taking oral contraceptives, hepatic adenomas 5 cm or smaller can be managed with serial imaging every 6 months; however, with larger adenomas, the risk for hemorrhage or malignant transformation is elevated and surgical resection should be considered.
- Men with hepatic adenomas of any size are at increased risk for malignant transformation, and resection is recommended
- Pregnancy can result in adenoma growth, and resection or ablation of adenomas can be considered if pregnancy is contemplated
Focal Nodular Hyperplasia
- Most common benign liver tumor and a frequent incidental finding
- Caused by a congenital arterial anomaly leading to a focal area of regeneration that appears as a stellate scar on CT or MRI.
- CT or MRI with and without contrast can confirm the diagnosis
- FNH typically does not have malignant potential or risk for bleeding and does not require follow-up.
- Seems there are some weak suggestions that women who continue to use oral contraceptives should get annual liver ultrasonography should be performed for a period of 2 to 3 years to assess the lesion for growth. It is unclear why, given no clear evidence it is hormonally stimulated, perhaps because it may be a misdiagnosed #Hepatic Adenoma
Hepatic Hemangiomas
- Benign (no potential for malignant transformation), common, and more frequent in women
- Hepatic hemangiomas are rarely symptomatic, and, in most cases, symptoms that might be ascribed to a hemangioma are due to other causes
- Hepatic hemangiomas do not require intervention or follow-up except in the rare instance when they cause symptoms
References:
Created on: Monday 08-14-2023